Friedrich Stölzel

7.1k total citations · 1 hit paper
92 papers, 1.9k citations indexed

About

Friedrich Stölzel is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Friedrich Stölzel has authored 92 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Hematology, 27 papers in Genetics and 21 papers in Oncology. Recurrent topics in Friedrich Stölzel's work include Acute Myeloid Leukemia Research (54 papers), Hematopoietic Stem Cell Transplantation (29 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). Friedrich Stölzel is often cited by papers focused on Acute Myeloid Leukemia Research (54 papers), Hematopoietic Stem Cell Transplantation (29 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). Friedrich Stölzel collaborates with scholars based in Germany, United States and Italy. Friedrich Stölzel's co-authors include Martin Bornhäuser, Gerhard Ehninger, Markus Schaich, Christoph Röllig, Uwe Platzbecker, Brigitte Mohr, Frank Kroschinsky, Michael Krämer, Malte von Bonin and Johannes Schetelig and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Friedrich Stölzel

85 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management

2017 331 citations Frank Kroschinsky, Friedrich Stölzel et al. profile →

Peers

Friedrich Stölzel

HEMAT

GENET

ONCOL

PHEOH

Frank Kroschinsky Germany

Argiris Symeonidis Greece

Danielle M. Townsley United States

Lucía López‐Corral Spain

Michael Keeney Canada

Olga Frankfurt United States

Michael Medinger Switzerland

J Treleaven United Kingdom

Depei Wu China

G.J. Ossenkoppele Netherlands

Frank Kroschinsky Germany

Friedrich Stölzel

875 ×0.9

HEMAT

674 ×1.2

GENET

277 ×0.5

598 ×1.5

ONCOL

232 ×1.0

PHEOH

Citations per year, relative to Friedrich Stölzel Friedrich Stölzel (= 1×) peers Frank Kroschinsky

Countries citing papers authored by Friedrich Stölzel

Since Specialization

Citations

This map shows the geographic impact of Friedrich Stölzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedrich Stölzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedrich Stölzel more than expected).

Fields of papers citing papers by Friedrich Stölzel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedrich Stölzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedrich Stölzel. The network helps show where Friedrich Stölzel may publish in the future.

Co-authorship network of co-authors of Friedrich Stölzel

This figure shows the co-authorship network connecting the top 25 collaborators of Friedrich Stölzel. A scholar is included among the top collaborators of Friedrich Stölzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedrich Stölzel. Friedrich Stölzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dargvainiene, Justina, et al.. (2026). Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report. Frontiers in Immunology. 17. 1749587–1749587.

Halter, Jörg, Friedrich Stölzel, Markus Perl, et al.. (2025). Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis. Bone Marrow Transplantation. 60(4). 439–446. 6 indexed citations

Holland, Petter, Tobias Gedde‐Dahl, Jochen Buechner, et al.. (2024). Epigenetic aging of human blood cells is influenced by the age of the host body. Aging Cell. 23(5). e14112–e14112. 3 indexed citations

Beelen, Dietrich W., Simona Iacobelli, Linda Köster, et al.. (2024). Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison. Bone Marrow Transplantation. 59(5). 670–679. 3 indexed citations

Galimard, Jacques‐Emmanuel, Ali Bazarbachi, Jürgen Finke, et al.. (2024). Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients. Blood Cancer Journal. 14(1). 76–76. 3 indexed citations

Fransecky, Lars, Thomas Valerius, Natalie Schub, et al.. (2024). Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities. Intensive Care Medicine. 50(9). 1459–1469. 17 indexed citations

Nagler, Arnon, Myriam Labopin, Alexander Kulagin, et al.. (2023). Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation. 58(9). 1008–1016. 4 indexed citations

Sockel, Katja, Friedrich Stölzel, Christoph Röllig, et al.. (2022). Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse. SHILAP Revista de lepidopterología. 3 indexed citations

Jambor, Helena, Friedrich Stölzel, Leo Ruhnke, et al.. (2022). Next Generation Biobanking: Employing a Robotic System for Automated Mononuclear Cell Isolation. Biopreservation and Biobanking. 21(1). 106–110. 1 indexed citations

10.

Eckardt, Jan‐Niklas, Michael Krämer, Katja Sockel, et al.. (2022). Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears. BMC Cancer. 22(1). 201–201. 41 indexed citations

11.

Krämer, Michael, Heidi Altmann, Lisa Wagenführ, et al.. (2020). Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia. Biomarker Research. 8(1). 20–20. 8 indexed citations

12.

Stölzel, Friedrich, Steffen Löck, Stefani Parmentier, et al.. (2019). The prevalence of extramedullary acute myeloid leukemia detected by ¹⁸FDG-PET/CT: final results from the prospective PETAML trial. Haematologica. 105(6). 1552–1558. 34 indexed citations

13.

Heidrich, Katharina, Malte von Bonin, Friedrich Stölzel, et al.. (2018). Pilot Study on Mass Spectrometry–Based Analysis of the Proteome of CD34+CD123+ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia. Proteomes. 6(1). 11–11. 10 indexed citations

14.

Stölzel, Friedrich, Kirsty Cuthill, Charlotte Graham, et al.. (2018). Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation. Leukemia. 32(9). 2020–2024. 20 indexed citations

15.

Wermke, Martin, Katharina S. Götze, Stefan Klein, et al.. (2018). Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial. The Lancet Haematology. 5(5). e201–e210. 42 indexed citations

16.

Rößler, Susann, Oliver Bader, Friedrich Stölzel, et al.. (2017). Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR ₄₆ Y121F M172I T289A Allele. Antimicrobial Agents and Chemotherapy. 61(8). 8 indexed citations

17.

Bochtler, Tilmann, Friedrich Stölzel, Christoph E. Heilig, et al.. (2013). Clonal Heterogeneity As Detected by Metaphase Karyotyping Is an Indicator of Poor Prognosis in Acute Myeloid Leukemia. Journal of Clinical Oncology. 31(31). 3898–3905. 51 indexed citations

18.

Poitz, David M., Friedrich Stölzel, Jens Friedrichs, et al.. (2013). MiR-134-mediated β1 integrin expression and function in mesenchymal stem cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(12). 3396–3404. 17 indexed citations

19.

Stölzel, Friedrich, Karl Hackmann, Brigitte Mohr, et al.. (2012). Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation. 93(7). 744–749. 37 indexed citations

20.

Stölzel, Friedrich, Markus Pfirrmann, Walter E. Aulitzky, et al.. (2010). Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial. Leukemia. 25(3). 420–428. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact